Literature DB >> 20732766

Impact of the radiation boost on outcomes after breast-conserving surgery and radiation.

Colin Murphy1, Penny R Anderson, Tianyu Li, Richard J Bleicher, Elin R Sigurdson, Lori J Goldstein, Ramona Swaby, Crystal Denlinger, Holly Dushkin, Nicos Nicolaou, Gary M Freedman.   

Abstract

PURPOSE: We examined the impact of radiation tumor bed boost parameters in early-stage breast cancer on local control and cosmetic outcomes. METHODS AND MATERIALS: A total of 3,186 women underwent postlumpectomy whole-breast radiation with a tumor bed boost for Tis to T2 breast cancer from 1970 to 2008. Boost parameters analyzed included size, energy, dose, and technique. Endpoints were local control, cosmesis, and fibrosis. The Kaplan-Meier method was used to estimate actuarial incidence, and a Cox proportional hazard model was used to determine independent predictors of outcomes on multivariate analysis (MVA). The median follow-up was 78 months (range, 1-305 months).
RESULTS: The crude cosmetic results were excellent in 54%, good in 41%, and fair/poor in 5% of patients. The 10-year estimate of an excellent cosmesis was 66%. On MVA, independent predictors for excellent cosmesis were use of electron boost, lower electron energy, adjuvant systemic therapy, and whole-breast IMRT. Fibrosis was reported in 8.4% of patients. The actuarial incidence of fibrosis was 11% at 5 years and 17% at 10 years. On MVA, independent predictors of fibrosis were larger cup size and higher boost energy. The 10-year actuarial local failure was 6.3%. There was no significant difference in local control by boost method, cut-out size, dose, or energy.
CONCLUSIONS: Likelihood of excellent cosmesis or fibrosis are associated with boost technique, electron energy, and cup size. However, because of high local control and rare incidence of fair/poor cosmesis with a boost, the anatomy of the patient and tumor cavity should ultimately determine the necessary boost parameters.
Copyright © 2011 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2010        PMID: 20732766      PMCID: PMC2992091          DOI: 10.1016/j.ijrobp.2010.04.067

Source DB:  PubMed          Journal:  Int J Radiat Oncol Biol Phys        ISSN: 0360-3016            Impact factor:   7.038


  18 in total

1.  The impact of tamoxifen on breast recurrence, cosmesis, complications, and survival in estrogen receptor-positive early-stage breast cancer.

Authors:  B Fowble; D A Fein; A L Hanlon; B L Eisenberg; J P Hoffman; E R Sigurdson; M B Daly; L J Goldstein
Journal:  Int J Radiat Oncol Biol Phys       Date:  1996-07-01       Impact factor: 7.038

2.  Determination of depth for electron breast boosts.

Authors:  L J Solin; J C Chu; R Larsen; B Fowble; J M Galvin; R L Goodman
Journal:  Int J Radiat Oncol Biol Phys       Date:  1987-12       Impact factor: 7.038

3.  Inaccuracies in using the lumpectomy scar for planning electron boosts in primary breast carcinoma.

Authors:  M Machtay; R Lanciano; J Hoffman; G E Hanks
Journal:  Int J Radiat Oncol Biol Phys       Date:  1994-08-30       Impact factor: 7.038

4.  A practical technique for the localization of the tumor volume in definitive irradiation of the breast.

Authors:  L J Solin; B F Danoff; G F Schwartz; J M Galvin; R L Goodman
Journal:  Int J Radiat Oncol Biol Phys       Date:  1985-06       Impact factor: 7.038

5.  Surgical clips in planning the electron boost in breast cancer: a qualitative and quantitative evaluation.

Authors:  K J Harrington; M Harrison; P Bayle; K Evans; P A Dunn; H E Lambert; Z Saidan; J Lynn; J S Stewart
Journal:  Int J Radiat Oncol Biol Phys       Date:  1996-02-01       Impact factor: 7.038

6.  Radiotherapy for invasive breast cancer in North America and Europe: results of a survey.

Authors:  Elizabeth Ceilley; Reshma Jagsi; Saveli Goldberg; Laurent Grignon; Lisa Kachnic; Simon Powell; Alphonse Taghian
Journal:  Int J Radiat Oncol Biol Phys       Date:  2005-02-01       Impact factor: 7.038

7.  Role of a 10-Gy boost in the conservative treatment of early breast cancer: results of a randomized clinical trial in Lyon, France.

Authors:  P Romestaing; Y Lehingue; C Carrie; R Coquard; X Montbarbon; J M Ardiet; N Mamelle; J P Gérard
Journal:  J Clin Oncol       Date:  1997-03       Impact factor: 44.544

8.  Clinical implementation of intensity-modulated tangential beam irradiation for breast cancer.

Authors:  J S Li; G M Freedman; R Price; L Wang; P Anderson; L Chen; W Xiong; J Yang; A Pollack; C M Ma
Journal:  Med Phys       Date:  2004-05       Impact factor: 4.071

9.  Breast intensity-modulated radiation therapy reduces time spent with acute dermatitis for women of all breast sizes during radiation.

Authors:  Gary M Freedman; Tianyu Li; Nicos Nicolaou; Yan Chen; Charlie C-M Ma; Penny R Anderson
Journal:  Int J Radiat Oncol Biol Phys       Date:  2009-04-11       Impact factor: 7.038

10.  Impact of concurrent versus sequential tamoxifen with radiation therapy in early-stage breast cancer patients undergoing breast conservation treatment.

Authors:  Eleanor E R Harris; Vasthi J Christensen; Wei-Ting Hwang; Kevin Fox; Lawrence J Solin
Journal:  J Clin Oncol       Date:  2004-11-15       Impact factor: 44.544

View more
  3 in total

1.  Cosmetic outcome 1-5 years after breast conservative surgery, irradiation and systemic therapy.

Authors:  Gyöngyi Kelemen; Zoltán Varga; György Lázár; László Thurzó; Zsuzsanna Kahán
Journal:  Pathol Oncol Res       Date:  2011-10-08       Impact factor: 3.201

2.  Society of Surgical Oncology-American Society for Radiation Oncology consensus guideline on margins for breast-conserving surgery with whole-breast irradiation in stages I and II invasive breast cancer.

Authors:  Meena S Moran; Stuart J Schnitt; Armando E Giuliano; Jay R Harris; Seema A Khan; Janet Horton; Suzanne Klimberg; Mariana Chavez-MacGregor; Gary Freedman; Nehmat Houssami; Peggy L Johnson; Monica Morrow
Journal:  Int J Radiat Oncol Biol Phys       Date:  2014-03-01       Impact factor: 7.038

3.  Hypofractionation with concomitant boost using intensity-modulated radiation therapy in early-stage breast cancer in Mexico.

Authors:  María Yicel Bautista Hernandez; Pomponio José Lujan Castilla; Abril Antonia Quézada Bautista
Journal:  Rep Pract Oncol Radiother       Date:  2018-07-26
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.